AOD-9604 Import Supplier — Mexico
Research Use Only: All compounds supplied by Aarise Healthcare are strictly for laboratory research and scientific investigation. Not intended for human consumption, therapeutic use, or clinical application. All purchases must comply with applicable local laws and regulations.
Aarise Healthcare exports AOD-9604 (CAS: 221231-10-3) to research institutions in Mexico. Our WHO-GMP certified facility in India supplies 98%+ purity AOD-9604 for lipolytic peptide and fat metabolism research.
AOD-9604 Export Specifications for Mexico
| Compound | AOD-9604 |
| CAS Number | 221231-10-3 |
| Purity | 98%+ (HPLC verified) |
| Form | Lyophilised powder |
| Regulatory Reference | COFEPRIS |
| Shipping | DHL/FedEx temperature-controlled |
| Transit to Mexico | 5-10 business days |
| Documentation | CoA, HPLC, MS, export docs |
Research Applications of AOD-9604
AOD-9604 is used in lipolytic peptide and fat metabolism research. Research institutions in Mexico source this compound for preclinical studies under applicable COFEPRIS research regulations.
Why Mexico Researchers Source AOD-9604 from India
- WHO-GMP certified Indian manufacturer — internationally recognised compliance
- Competitive pricing for bulk research quantities
- Full export documentation package for COFEPRIS compliance
- Temperature-controlled DHL/FedEx shipping to Mexico
- Dedicated international research supply team
- 98%+ purity guaranteed with independent third-party CoA
Related Peptides in Mexico
Semaglutide in Mexico | Tirzepatide in Mexico | Retatrutide in Mexico | Liraglutide in Mexico
AOD-9604 — Other Countries
AOD-9604 in USA | AOD-9604 in UK | AOD-9604 in Germany | AOD-9604 in Australia
Source from India — Key Manufacturing Cities
AOD-9604 in Mumbai, India | AOD-9604 in Delhi, India | AOD-9604 in Hyderabad, India | AOD-9604 in Bangalore, India
Request AOD-9604 for your Mexico research facility: Send your institution details and quantity requirements. We respond within 24 hours with FOB pricing and export documentation.




